Oct 12, 2022 / 12:00PM GMT
Lynne Marie Sullivan - Unity Biotechnology, Inc. - CFO & Head of Corporate Development
Good morning, everyone. Thank you for joining Unity Biotechnologies Analyst/Investor conference call. With me today is our CEO, Anirvan Ghosh; our CMO, Jamie Dananberg; our Chief Scientific Adviser, Mike Sapieha; myself, Lynne Sullivan, the CFO. And we're fortunate today to have Dr. Robert Bhisitkul, Professor of Ophthalmology and Head of the Retina fellowship at University of California, San Francisco.
Before turning the call over to Anirvan, I'd like to remind you that during today's call, we'll be making some forward-looking statements, which are subject to risks and uncertainties, including those described in our latest 10-Q filed with the SEC. Actual results may materially differ from those forward-looking statements, and we don't assume any obligation or intent to update them, except as required by law.
So with that, I'll turn the discussion to Anirvan.
Anirvan Ghosh - Unity Biotechnology, Inc. - CEO & Director
Thank you, Lynne, and welcome,
UNITY Biotechnology Inc Analyst Day Transcript
Oct 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers